5-iodo-3-(2-azetidinylmethoxy)pyridine

structure in first source

Also Known As:

(S)-5-(123I)iodo-3-(2-azetidinylmethoxy)pyridine; 123I-5-iodo-3-(2(S)-2-azetidinylmethoxy)pyridine; 123I-5IA-85380; 5-(123I)-iodo-A-85380; 5-I-A-85380; 5-IA-85380; 5-iodo-A-85380

Networked: 5 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyridines: 88
    - 5-iodo-3-(2-azetidinylmethoxy)pyridine: 5
  - Azetines
    - Azetidines: 6
      - 5-iodo-3-(2-azetidinylmethoxy)pyridine: 5

Experts

1.	Colloby, Sean J: 3 articles (11/2016 - 04/2008)
2.	O'Brien, John T: 3 articles (11/2016 - 04/2008)
3.	Wyper, David J: 3 articles (11/2016 - 04/2008)
4.	McKeith, Ian G: 2 articles (01/2010 - 04/2008)
5.	Pakrasi, Sanjeet: 2 articles (01/2010 - 04/2008)
6.	Perry, Elaine K: 2 articles (01/2010 - 04/2008)
7.	Pimlott, Sally L: 2 articles (01/2010 - 04/2008)
8.	Williams, E David: 2 articles (01/2010 - 04/2008)
9.	Perry, E K: 2 articles (04/2007 - 01/2004)
10.	Pimlott, S L: 2 articles (04/2007 - 01/2004)

Related Diseases

1.	Dementia (Dementias) 01/01/2010 - "Nicotinic 123I-5IA-85380 single photon emission computed tomography as a predictor of cognitive progression in Alzheimer's disease and dementia with Lewy bodies." 04/15/2008 - "Nicotinic alpha4beta2 receptor binding in dementia with Lewy bodies using 123I-5IA-85380 SPECT demonstrates a link between occipital changes and visual hallucinations." 01/01/2004 - "In conclusion, 5-I-A-85380 is clearly a useful ligand for both in vitro and in vivo single photon emission tomography human studies investigating disease symptoms and progression, response to acetylcholinesterase-inhibiting drugs and in differentiating primary degenerative dementia from VaD."
2.	Alzheimer Disease (Alzheimer's Disease) 01/01/2010 - "Nicotinic 123I-5IA-85380 single photon emission computed tomography as a predictor of cognitive progression in Alzheimer's disease and dementia with Lewy bodies." 11/01/2016 - "A spatial covariance 123I-5IA-85380 SPECT study of α4β2 nicotinic receptors in Alzheimer's disease." 04/01/2007 - "32 non-smoking subjects (16 with Alzheimer's disease and 16 normal elderly controls) underwent 123I-5IA-85380 and perfusion (99mTc-hexamethylenepropyleneamine oxime (HMPAO)) SPECT scanning. " 04/01/2007 - "Alpha4beta2 nicotinic receptor status in Alzheimer's disease using 123I-5IA-85380 single-photon-emission computed tomography."
3.	Hallucinations (Hallucination) 04/15/2008 - "Nicotinic alpha4beta2 receptor binding in dementia with Lewy bodies using 123I-5IA-85380 SPECT demonstrates a link between occipital changes and visual hallucinations."

Related Drugs and Biologics

1.	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)
2.	Ligands
3.	Acetylcholinesterase
4.	Oximes
5.	nicotinic receptor alpha4beta2